Payment overview · 2025
General Payments
$22.90
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dinkar N Patel, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GRUNDY, VA · NPI 1831168004
Verified facts
What the public records show
CMS Open Payments records show Dinkar N Patel, M.D. received $22.90 in general payments during 2025 across 1 reported records.
Verona Pharma, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $22.90 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $22.90 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $22.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 602 | 78 |
| Losartan Potassium | Losartan Potassium | 587 | 92 |
| Pantoprazole Sodium | Pantoprazole Sodium | 548 | 92 |
| Omeprazole | Omeprazole | 532 | 77 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 487 | 111 |
| Levothyroxine Sodium | Levothyroxine Sodium | 480 | 79 |
| Amlodipine Besylate | Amlodipine Besylate | 448 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 414 | 64 |
| Atorvastatin Calcium | Atorvastatin Calcium | 412 | 76 |
| Metformin Hcl | Metformin Hcl | 320 | 45 |
| Potassium Chloride | Potassium Chloride | 320 | 59 |
| Furosemide | Furosemide | 313 | 57 |
| Ibuprofen | Ibuprofen | 301 | 49 |
| Simvastatin | Simvastatin | 301 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 295 | 39 |
| Meloxicam | Meloxicam | 289 | 52 |
| Lisinopril | Lisinopril | 269 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 238 | 40 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 233 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 228 | 51 |
| Tramadol Hcl | Tramadol Hcl | 215 | 29 |
| Glimepiride | Glimepiride | 200 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 192 | 29 |
| Azithromycin | Azithromycin | 154 | 100 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 27 |
| Montelukast Sodium | Montelukast Sodium | 150 | 22 |
| Prednisone | Prednisone | 146 | 44 |
| Sertraline Hcl | Sertraline Hcl | 137 | 17 |
| Metoprolol Succinate | Metoprolol Succinate | 136 | 30 |
| Clonazepam | Clonazepam | 133 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 132 | 18 |
| Famotidine | Famotidine | 132 | 25 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 131 | 17 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 130 | 19 |
| Meclizine Hcl | Meclizine Hcl | 129 | 42 |
| Naproxen | Naproxen | 126 | 27 |
| Ondansetron Odt | Ondansetron | 120 | 30 |
| Amoxicillin | Amoxicillin | 110 | 53 |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 104 | 16 |
| Sucralfate | Sucralfate | 103 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 94 | 19 |
| Allopurinol | Allopurinol | 91 | 17 |
| Glipizide | Glipizide | 88 | 11 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 87 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 86 | suppressed |
| Dutasteride | Dutasteride | 84 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 81 | 23 |
| Mirtazapine | Mirtazapine | 78 | 11 |
| Atenolol | Atenolol | 77 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 76 | 13 |
| Buspirone Hcl | Buspirone Hcl | 75 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 75 | 13 |
| Spironolactone | Spironolactone | 75 | 13 |
| Cefuroxime | Cefuroxime Axetil | 68 | 48 |
| Diclofenac Sodium | Diclofenac Sodium | 67 | 18 |
| Linzess | Linaclotide | 67 | 13 |
| Levofloxacin | Levofloxacin | 66 | 28 |
| Amitriptyline Hcl | Amitriptyline Hcl | 63 | suppressed |
| Carvedilol | Carvedilol | 60 | suppressed |
| Finasteride | Finasteride | 59 | suppressed |
| Alprazolam | Alprazolam | 58 | 17 |
| Clonidine Hcl | Clonidine Hcl | 58 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 56 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 17 |
| Mounjaro | Tirzepatide | 54 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 53 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 52 | 28 |
| Ezetimibe | Ezetimibe | 51 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | suppressed |
| Lorazepam | Lorazepam | 50 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 48 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 48 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 47 | suppressed |
| Januvia | Sitagliptin Phosphate | 46 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 44 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 44 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 43 | 18 |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 38 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 37 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Digoxin | Digoxin | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 34 | 16 |
| Eliquis | Apixaban | 34 | suppressed |
| Fluconazole | Fluconazole | 33 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 33 | suppressed |
| Pregabalin | Pregabalin | 32 | suppressed |
| Jardiance | Empagliflozin | 31 | suppressed |
| Cephalexin | Cephalexin | 30 | 18 |
| Estradiol | Estradiol | 30 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Mupirocin | Mupirocin | 29 | 23 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | suppressed |
| Baclofen | Baclofen | 26 | suppressed |
| Loperamide | Loperamide Hcl | 25 | 12 |
| Metformin Hcl Er | Metformin Hcl | 25 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 25 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 25 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Glipizide Er | Glipizide | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Ozempic | Semaglutide | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Nabumetone | Nabumetone | 22 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 19 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 18 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 18 | 18 |
| Topiramate | Topiramate | 18 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 17 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Methylprednisolone | Methylprednisolone | 16 | 14 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 16 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 14 | 13 |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 14 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 13 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Sulfasalazine | Sulfasalazine | 13 | suppressed |
| Veo Insulin Syringe | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Cefdinir | Cefdinir | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Comfort Ez Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Humulin R | Insulin Regular, Human | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Ursodiol | Ursodiol | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Xarelto | Rivaroxaban | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $22.90 · 1 records | Verona Pharma, Inc. | Ohtuvayre | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error